Guidelines for ATC classification and DDD assignment - WHOCC

The DDDs for calcium folinate, calcium levofolinate, sodium
folinate and sodium levofolinate are based on the combined
treatment with high doses of methotrexate.
The DDD for amifostine is based on the use as an adjunct in
antineoplastic therapy.
V03AG Drugs for treatment of hypercalcemia
Sodium cellulose phosphate is classified here.
See also M05 - Drugs for treatment of bone diseases.
V03AH Drugs for treatment of hypoglycemia
Oral preparations containing diazoxide for treatment of hypoglycemia,
are classified in this group, while parenteral preparations used for
treatment of hypertension, are classified in C02DA.
V03AK Tissue adhesives
Human fibrinogen for systemic use is classified in B02BB01.
Fibrin sealants providing hemostasis at the site of application should be
classified in B02BC.
V03AM Drugs for embolisation
V03AN Medical gases
Nitric oxide used in respiratory conditions is classified in R07AX.
V03AX Other therapeutic products
This group comprises agents, which cannot be classified in the
preceding groups.
V03AZ Nerve depressants
261